Science Update: Drug combination may lead to slight bone loss in young adolescent males, NIH-funded analysis suggests
Truvada, a drug combination that reduces the chances of HIV infection in high-risk people may result in small, yet persistent bone loss in younger adolescent males, suggests a study supported by the NICHD. The researchers added, however, that the protection against HIV offered by Truvada far outweighs any possible risks from bone loss.